Teva Pharmaceutical Banks on Thrice-weekly Copaxone

02.05.2013 - Teva Pharmaceutical Industries is banking on approval in early 2014 for a new thrice-weekly version of its multiple sclerosis treatment Copaxone to bolster sales ahead of a likely...